Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8787447rdf:typepubmed:Citationlld:pubmed
pubmed-article:8787447lifeskim:mentionsumls-concept:C0086661lld:lifeskim
pubmed-article:8787447lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:8787447lifeskim:mentionsumls-concept:C0078974lld:lifeskim
pubmed-article:8787447lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:8787447pubmed:issue6lld:pubmed
pubmed-article:8787447pubmed:dateCreated1996-9-24lld:pubmed
pubmed-article:8787447pubmed:abstractTextMutation or deregulation of certain cellular genes (protooncogenes) results in expression of proteins that appear to promote malignant transformation. Human non-small cell lung cancer has been documented to express many such oncogenes including c-myc, bcl-2, and mutant p53. Antisense oligodeoxyribonucleotides (ASODN) complementary to these oncogenes were tested on three non-small cell lung cancer cell lines for their efficacy in inhibiting cellular proliferation and oncoprotein expression.lld:pubmed
pubmed-article:8787447pubmed:languageenglld:pubmed
pubmed-article:8787447pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8787447pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8787447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8787447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8787447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8787447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8787447pubmed:statusMEDLINElld:pubmed
pubmed-article:8787447pubmed:monthDeclld:pubmed
pubmed-article:8787447pubmed:issn0003-4975lld:pubmed
pubmed-article:8787447pubmed:authorpubmed-author:SmithL JLJlld:pubmed
pubmed-article:8787447pubmed:authorpubmed-author:RobinsonL ALAlld:pubmed
pubmed-article:8787447pubmed:authorpubmed-author:KayH DHDlld:pubmed
pubmed-article:8787447pubmed:authorpubmed-author:FontaineM PMPlld:pubmed
pubmed-article:8787447pubmed:authorpubmed-author:PirruccelloS...lld:pubmed
pubmed-article:8787447pubmed:authorpubmed-author:MountjoyC PCPlld:pubmed
pubmed-article:8787447pubmed:issnTypePrintlld:pubmed
pubmed-article:8787447pubmed:volume60lld:pubmed
pubmed-article:8787447pubmed:ownerNLMlld:pubmed
pubmed-article:8787447pubmed:authorsCompleteYlld:pubmed
pubmed-article:8787447pubmed:pagination1583-91lld:pubmed
pubmed-article:8787447pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:meshHeadingpubmed-meshheading:8787447-...lld:pubmed
pubmed-article:8787447pubmed:year1995lld:pubmed
pubmed-article:8787447pubmed:articleTitlec-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.lld:pubmed
pubmed-article:8787447pubmed:affiliationDivision of Cardiovascular and Thoracic Surgery, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa 33612-9497, USA.lld:pubmed
pubmed-article:8787447pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8787447lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8787447lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8787447lld:pubmed